Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Q3 2020 Johnson & Johnson Earnings Call Transcript

Oct 13, 2020 / 12:30PM GMT
Release Date Price: €126.3 (-2.17%)
Operator

Good morning, and welcome to Johnson & Johnson's Third Quarter 2020 Earnings Conference Call. (Operator Instructions) This call is being recorded. (Operator Instructions)

I would now like to turn the conference call over to Johnson & Johnson. You may begin.

Christopher DelOrefice
Johnson & Johnson - VP of IR

Good morning. This is Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the third quarter of 2020. I hope everyone is healthy and continues to remain safe during these times.

Joining me on today's call is Joe Wolk, Executive Vice President and Chief Financial Officer. During the Q&A portion of the call, we're joined by Jennifer Taubert, Executive Vice President and Worldwide Chairman, Pharmaceuticals; Ashley McEvoy, Executive Vice President and Worldwide Chairman, Medical Devices; Thibaut Mongon, Executive Vice President and Worldwide Chairman, Consumer Health; and Mathai Mammen, Global Head of Janssen Research and Development.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot